Andreas Halvorsen - Viking Global Investors
Holding/activity history for Day One Biopharmaceuticals I (DAWN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | 0 | 0.00 | Sell 100.00% | 0.13 | SEC | ||
| 2024 Q3 | 2,558,563 | 0.13 | $13.93 | $35,640,783 | SEC | ||
| 2024 Q2 | 2,558,563 | 0.14 | $13.78 | $35,256,998 | SEC | ||
| 2024 Q1 | 2,558,563 | 0.16 | $16.52 | $42,267,461 | SEC | ||
| 2023 Q4 | 2,558,563 | 0.14 | $14.60 | $37,355,020 | SEC | ||
| 2023 Q3 | 2,558,563 | 0.13 | $12.27 | $31,393,568 | SEC | ||
| 2023 Q2 | 2,558,563 | 0.13 | Add 64.16% | 0.05 | $11.94 | $30,549,242 | SEC |
| 2023 Q1 | 1,558,563 | 0.10 | $13.37 | $20,837,987 | SEC | ||
| 2022 Q4 | 1,558,563 | 0.17 | $21.52 | $33,540,276 | SEC | ||
| 2022 Q3 | 1,558,563 | 0.14 | Reduce 16.09% | 0.02 | $20.03 | $31,218,000 | SEC |
| 2022 Q2 | 1,857,424 | 0.15 | Add 60.48% | 0.06 | $17.90 | $33,248,000 | SEC |
| 2022 Q1 | 1,157,424 | 0.05 | $9.92 | $11,482,000 | SEC | ||
| 2021 Q4 | 1,157,424 | 0.06 | Reduce 4.46% | <0.01 | $16.85 | $19,503,000 | SEC |
| 2021 Q3 | 1,211,396 | 0.08 | Reduce 9.69% | <0.01 | $23.73 | $28,746,000 | SEC |
| 2021 Q2 | 1,341,396 | 0.09 | Buy | 0.09 | $22.77 | $30,544,000 | SEC |